Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
LIDDS logo — LIDDS is a Swedish drug delivery company based on the propr...

LIDDS

LIDDS is a Swedish drug delivery company based on the proprietary technology NanoZolid®

Founded 2003 Sweden Sweden 2 employees Convertible Note Total: $40.80M Biotechnology, Health Care

General Information

Company Name LIDDS
Founded Year 2003
Location Sweden Sweden
Founders / Decision Makers
Team member
Employees 2
Industries Biotechnology, Health Care
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with LIDDS . To contact LIDDS , visit liddspharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About LIDDS

LIDDS

LIDDS is a Swedish drug delivery company based on the proprietary technology NanoZolid®. With NanoZolid®, LIDDS can formulate drugs for local administration, with a maintained and controlled release for up to six months.

Founded in 2003, the company operates in the Biotechnology and Health Care industries, with its headquarters in Sweden.

The latest investment of kr40.80M came in the form of a Convertible Note investment at 22 February 2022, with Nice & Green SA as the investor.

Taxonomy: Swedish company, drug delivery, NanoZolid® technology, formulation of drugs, local administration, controlled release, sustained release, pharmaceutical technology, biomedical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note kr40.80M 1
Nice & Green SA
Nice & Green SA
22 Feb 2022

LIDDS Alternatives & Competitors

View All Alternatives
LIDDS vs
Bostal Drug Delivery
Bostal Drug Delivery

Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...

Series B
Biotechnology, Health Care
LIDDS vs
PolyActiva
PolyActiva Australia

Enabling Drug Delivery from Medical Devices

Series B
24 employees
Biotechnology, Health Care
LIDDS vs
Softhale
Softhale

Advancing the future of lung drug delivery with innovative Soft Mist Inhalation devices

Series A
Biotechnology, Health Care
View all alternatives

FAQ About LIDDS

LIDDS is a Swedish drug delivery company based on the proprietary technology NanoZolid®
LIDDS was founded in 2003.
LIDDS is headquartered in Sweden.
LIDDS operates in Biotechnology and Health Care. Its work centres on Swedish company, drug delivery, NanoZolid® technology and formulation of drugs.
LIDDS has approximately 2 employees.
LIDDS has completed 1 funding round, raising a total of $40.80M. The latest funding stage is Convertible Note.
Top alternatives and competitors to LIDDS include Bostal Drug Delivery, PolyActiva, Softhale, ICO Therapeutics Inc (ICOTF), Plumb Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LIDDS and Bostal Drug Delivery are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for LIDDS , https://bouncewatch.com/company/lidds, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes